Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Mar 16;129(11):1415-1419.
doi: 10.1182/blood-2016-07-692673. Epub 2017 Feb 7.

Platelets and von Willebrand factor in atherogenesis

Affiliations
Review

Platelets and von Willebrand factor in atherogenesis

Melinda D Wu et al. Blood. .

Abstract

The role of platelet adhesion, activation, and aggregation in acute atherothrombotic events such as myocardial infarction and stroke is well established. There is increasing evidence that platelet-endothelial interactions also contribute to early atherosclerotic plaque initiation and growth. Through these interactions, platelet-derived factors can contribute to the proinflammatory and mitogenic status of resident mural cells. Among the many putative mechanisms for platelet-endothelial interactions, increased endothelial-associated von Willebrand factor, particularly in a multimerized form, which interacts with platelet glycoproteins and integrins, is a major factor and represents a therapeutic target in early atherogenesis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Schematic illustration of potential mechanisms and proatherogenic effects of platelet-endothelial interactions. EC, endothelial cell; LDL, low-density lipoprotein; UL, ultralarge.

Similar articles

Cited by

References

    1. Gryglewski RJ, Chłopicki S, Uracz W, Marcinkiewicz E. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation. Med Sci Monit. 2001;7(1):1-16. - PubMed
    1. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109(23 suppl 1):III27-III32. - PubMed
    1. Kanthi Y, Hyman MC, Liao H, et al. . Flow-dependent expression of ectonucleotide tri(di)phosphohydrolase-1 and suppression of atherosclerosis. J Clin Invest. 2015;125(8):3027-3036. - PMC - PubMed
    1. Borissoff JI, Spronk HM, ten Cate H. The hemostatic system as a modulator of atherosclerosis. N Engl J Med. 2011;364(18):1746-1760. - PubMed
    1. Laszik ZG, Zhou XJ, Ferrell GL, Silva FG, Esmon CT. Down-regulation of endothelial expression of endothelial cell protein C receptor and thrombomodulin in coronary atherosclerosis. Am J Pathol. 2001;159(3):797-802. - PMC - PubMed

Publication types

Substances

-